Dr. Rangaswamy Govindarajan
Claim this profileJohn L McClellan Memorial Veterans Hospital
Studies Cancer
Studies Lung Cancer
9 reported clinical trials
41 drugs studied
Area of expertise
1Cancer
Stage IV
Stage III
Stage I
2Lung Cancer
Stage IV
ALK positive
Stage I
Affiliated Hospitals
Clinical Trials Rangaswamy Govindarajan is currently running
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Duloxetine
for Colorectal Cancer
This phase II/III trial studies the best dose of duloxetine and how well it works in preventing pain, tingling, and numbness (peripheral neuropathy) caused by treatment with oxaliplatin in patients with stage II-III colorectal cancer. Duloxetine increases the amount of certain chemicals in the brain that help relieve depression and pain. Giving duloxetine in patients undergoing treatment with oxaliplatin for colorectal cancer may help prevent peripheral neuropathy.
Recruiting0 awards Phase 2 & 33 criteria
More about Rangaswamy Govindarajan
Clinical Trial Related6 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Rangaswamy Govindarajan has experience with
- Crizotinib
- Abiraterone Acetate
- Cabazitaxel
- Antiandrogen Therapy
- Prednisone
- Capivasertib
Breakdown of trials Rangaswamy Govindarajan has run
Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Prostate Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Rangaswamy Govindarajan specialize in?
Rangaswamy Govindarajan focuses on Cancer and Lung Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage III.
Is Rangaswamy Govindarajan currently recruiting for clinical trials?
Yes, Rangaswamy Govindarajan is currently recruiting for 6 clinical trials in Little Rock Arkansas. If you're interested in participating, you should apply.
Are there any treatments that Rangaswamy Govindarajan has studied deeply?
Yes, Rangaswamy Govindarajan has studied treatments such as Crizotinib, Abiraterone Acetate, Cabazitaxel.
What is the best way to schedule an appointment with Rangaswamy Govindarajan?
Apply for one of the trials that Rangaswamy Govindarajan is conducting.
What is the office address of Rangaswamy Govindarajan?
The office of Rangaswamy Govindarajan is located at: John L McClellan Memorial Veterans Hospital, Little Rock, Arkansas 72205 United States. This is the address for their practice at the John L McClellan Memorial Veterans Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.